Mr. Arensdorf has specialized in the strategic positioning and development of medical technologies and companies for nearly 20 years with a breadth of experience ranging from medical supplies through implantable Class III medical devices and selling to over a dozen medical specialties. Most recently, he was Executive Vice President at Tethys Bioscience, where as a member of the founding management team, he managed the diagnostic company’s strategy, corporate development, finance, and administration functions through three venture financings and its initial product launch. Prior to this, Mr. Arensdorf was the CEO of First Medical, a pioneer in point-of-care cardiac diagnostics. He led this venture-backed startup company through its recapitalization, turnaround and acquisition by Sigma-Aldrich and continued at Sigma through product approvals, launch and initial sales growth. Mr. Arensdorf has previously been an interim CFO, general manager and private equity investor in several other diverse industries beginning his career as a strategic consultant and investment banker specializing in medical devices and supplies. He remains active in the creation of new healthcare products and ventures as an angel investor with Life Science Angels, and as a technology innovator, inventor and mentor with the Stanford Biodesign Program. Mr. Arensdorf received his bachelor’s degree in Molecular Biology with a certificate in East Asian Studies from Princeton University in Princeton, New Jersey, and his master of science in management from the Stanford Graduate School of Business in Stanford, California where he was a Sloan Fellow.